Indoco Remedies Second Quarter 2025 Earnings: ₹1.09 loss per share (vs ₹3.82 profit in 2Q 2024)

Simply Wall St · 10/26 02:14

Indoco Remedies (NSE:INDOCO) Second Quarter 2025 Results

Key Financial Results

  • Revenue: ₹4.34b (down 9.9% from 2Q 2024).
  • Net loss: ₹95.7m (down by 127% from ₹350.8m profit in 2Q 2024).
  • ₹1.09 loss per share (down from ₹3.82 profit in 2Q 2024).
earnings-and-revenue-growth
NSEI:INDOCO Earnings and Revenue Growth October 26th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Indoco Remedies Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.

Performance of the Indian Pharmaceuticals industry.

The company's shares are down 11% from a week ago.

Risk Analysis

You should learn about the 4 warning signs we've spotted with Indoco Remedies (including 2 which are potentially serious).